|
|
NPI Detail
NPI: 1548212988
Type: Organization
Taxonomy Code: 261QP2300X
3333 XXXXXX XXX
CINCINNATI, OH 45229
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1548212988*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 88185
|
FLOWCYTOMETRY/TC ADD-ON
|
XXXX
|
-
|
| 83883
|
ASSAY NEPHELOMETRY NOT SPEC
|
XXXX
|
$XXXXX.XX
|
| 88271
|
CYTOGENETICS DNA PROBE
|
XXXX
|
$XXXXX.XX
|
| 84155
|
ASSAY OF PROTEIN SERUM
|
XXXX
|
$XXXX.XX
|
| 84165
|
PROTEIN E-PHORESIS SERUM
|
XXXX
|
$XXXXX.XX
|
| 82610
|
CYSTATIN C
|
XXXX
|
$XX.XX
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXX
|
$XXXX.XX
|
| 88275
|
CYTOGENETICS 100-300
|
XXX
|
$XXXXX.XX
|
| 86334
|
IMMUNOFIX E-PHORESIS SERUM
|
XXX
|
$XXXXX.XX
|
| 36415
|
ROUTINE VENIPUNCTURE
|
XXX
|
$XXX
|
| 97530
|
THERAPEUTIC ACTIVITIES
|
XXX
|
$XXXXX.XX
|
| 90999
|
UNLISTED DIALYSIS PROCEDURE
|
XXX
|
$XXXXXX.XX
|
| 88237
|
TISSUE CULTURE BONE MARROW
|
XXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J0585
|
Injection,onabotulinumtoxina
|
XXXXX
|
$XXXXX.XX
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXX
|
-
|
| J2704
|
Inj, propofol, 10 mg
|
XXXX
|
-
|
| J0180
|
Agalsidase beta injection
|
XXXX
|
$XXXXXX.XX
|
| J1642
|
Inj heparin sodium per 10 u
|
XXXX
|
-
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXX
|
$XXX.XX
|
| J1575
|
Hyqvia 100mg immuneglobulin
|
XXXX
|
$XXXXX.XX
|
| J1644
|
Inj heparin sodium per 1000u
|
XXXX
|
-
|
| J7512
|
Prednisone ir or dr oral 1mg
|
XXXX
|
-
|
| J1569
|
Gammagard liquid injection
|
XXXX
|
$XXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXX
|
-
|
| J0485
|
Belatacept injection
|
XXXX
|
$XXXX.XX
|
| J1559
|
Hizentra injection
|
XXX
|
$XXXX.XX
|
| J0610
|
Calcium glucon (fresenius)
|
XXX
|
-
|
| J2501
|
Paricalcitol
|
XXX
|
-
|
| J3380
|
Injection, vedolizumab
|
XXX
|
$XXXX.XX
|
| J9271
|
Inj pembrolizumab
|
XXX
|
$XXXXX.XX
|
| J3060
|
Inj, taliglucerase alfa 10 u
|
XXX
|
$XXXXX.XX
|
| J3490
|
Drugs unclassified injection
|
XXX
|
-
|
| J0129
|
Abatacept injection
|
XXX
|
$XXXXX.XX
|
| J1745
|
Infliximab not biosimil 10mg
|
XXX
|
-
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXX
|
$XXXXX.XX
|
| G0378
|
Hospital observation per hr
|
XXX
|
-
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
